MI-LUNG
LIVE

Serial Number

97142051

Owner

Hummingbird Diagnostics GmbH

Attorney

Margaret C. McHugh

Filing Date

Nov 24, 2021

Add to watchlist:

No watchlists yet
View on USPTO

MI-LUNG Trademark

Serial Number: 97142051 • Registration: 7424334

MI-LUNG is a trademark filed by Hummingbird Diagnostics GmbH on November 24, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Hummingbird Diagnostics GmbH (7 trademarks)

Im Neuenheimer Feld 583
Heidelberg 69120 , DE

Entity Type: 16

Trademark Details

Filing Date

November 24, 2021

Registration Date

June 25, 2024

Published for Opposition

April 9, 2024

Goods & Services

Diagnostic preparations for medical use; diagnostic preparations for medical use and pharmaceutical research use; diagnostic preparations for medical purposes; sampling kits containing preparations for medical or pharmaceutical purposes use, namely, chemical reagents for sampling bodily fluids and tissue; test kits consisting of chemical reagents for medical purposes; kits consisting of chemical reagents for medical purposes

Chemicals for use in industry and science; reagents for use in industry and science; test and collection kits containing chemicals for use in industry and science; sampling kits containing chemicals for use in industry and science; diagnostic kits containing chemicals for use in industry and science

Medical and veterinary services; health care for humans and animals; medical and veterinary diagnostic testing, monitoring and reporting services in pre-clinical and clinical areas; medical and veterinary diagnostic testing, monitoring and reporting services for humans and animals; services of a diagnostic laboratory, namely, analysis, detection and identification of components in bodily samples and tissue; medical analysis services relating to the treatment of humans and animals; diagnostic services for determining diseases or disorders, monitoring diseases or disorders, and determining the therapeutic success of diseases or disorders; non-invasive medical diagnostic testing, monitoring and reporting services; blood and biopsy-based medical diagnostic testing, monitoring and reporting services; personalized medical diagnostic testing, monitoring and reporting services; medical services, namely, diagnostic health monitoring and health surveillance

Scientific and technological services, namely, scientific research, analysis, and testing in the field of disease diagnosis; scientific analysis and research services in the medical, biotechnological and equipment diagnostic fields; industrial analysis and research services in the medical, biotechnological and equipment diagnostic fields; research and related development of pharmaceutical products and substances; development of new medicines; scientific research services for diagnostic purposes; scientific research, namely, preparing scientific opinions; scientific research consulting; contract research in the field of pharmacological and clinical development of medicinal products; medical research services, namely, analysis of data and clinical trials

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 25, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 25, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 9, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 20, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 5, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 27, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 27, 2023 CRFA
ASSIGNED TO LIE
Jun 26, 2023 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 28, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 2, 2022 GNRN
NON-FINAL ACTION E-MAILED
Sep 2, 2022 GNRT
NON-FINAL ACTION WRITTEN
Sep 2, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 25, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 30, 2021 NWOS
NEW APPLICATION ENTERED
Nov 27, 2021 NWAP